A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy

A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy

Background: The survival rate of hepatocellular carcinoma (HCC) is low and the prognosis is poor. Metabolic reprogramming is still an emerging hallmark of cancer, and reprogramming of cholesterol metabolism plays a crucial action in tumor pathogenesis. Increasing evidence suggests that cholesterol m...

Full description

Bibliographic Details
Main Authors: Hui Lei, Tao Xiang, Hua Zhu, Xinyao Hu
Format: Article
Language:English
Published: IMR Press 2024-03-01
Series:Frontiers in Bioscience-Landmark
Subjects:
hcc
cholesterol metabolism
lncrna signature
prognosis biomarker
immune
Online Access:https://www.imrpress.com/journal/FBL/29/3/10.31083/j.fbl2903129

Internet

https://www.imrpress.com/journal/FBL/29/3/10.31083/j.fbl2903129

Similar Items